see how well it works compared with giving paclitaxel together with ifosfamide in treating
patients with newly diagnosed persistent or recurrent uterine, ovarian, fallopian tube, or
peritorium cavity cancer. Drugs used in chemotherapy, such as paclitaxel, carboplatin, and
ifosfamide, work in different ways to stop the growth of tumor cells, either by killing the
cells or by stopping them from dividing. It is not yet known whether paclitaxel is more
effective when given together with carboplatin or ifosfamide in treating patients with
uterine, ovarian, fallopian tube, or peritorium cavity cancer.
For more information about a clinical trial, clinical trial eligibility, or informed consent, contact our research nurses by phone or email:
- Cancer Help Line: (800) 639-6918
- Email: firstname.lastname@example.org
Please Note: Any eligibility criteria noted are subject to change. Our research nurses can provide you with the most current eligibility and exclusion criteria. Any study involvement to be undertaken must ultimately be determined on an individual basis.